iPACES for Parkinson's Disease (iPACES-PD Trial)

N/A

Waitlist Available

Led By Cay Anderson-Hanley, PhD

Research Sponsored by iPACES LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 3 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if an exercise system can improve cognitive ability for people with mild cognitive impairment or Parkinson's Disease. Participants will exercise at home 3-5 times/wk for 6+ mos, then be evaluated. Remote participation, own/supplied equipment, & measures.

Who is the study for?

This trial is for people over 50 with mild cognitive impairment or Parkinson's Disease who can commit to a year-long study, exercise 3-5 times weekly for at least 6 months using an under-table elliptical, and are comfortable with English. They need approval from their doctor to exercise and must be able to use touch screens despite any tremors.

What is being tested?

The study tests the iPACES system, a neuro-exergaming setup designed for home use that combines physical and cognitive exercises. Participants will engage in these activities remotely using either personal devices or equipment provided by the study.

What are the potential side effects?

While not explicitly stated, potential side effects may include typical exercise-related risks such as muscle strain or fatigue. The remote nature of the trial suggests minimal risk but participants should monitor for any discomfort related to technology use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

everyday function

executive function

Secondary study objectives

PD-ADLs

biomarker

visuospatial function

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iPACES (interactive Physical and Cognitive Exercise System)Experimental Treatment1 Intervention

iPACES (interactive Physical and Cognitive Exercise System) involves a "pedal-to-play" neuro-exergame in which physical and mental exercise are combined in an interactive way. In this condition a person will pedal to control forward motion in a tablet-based game, such as when pedaling along a virtual path and steering to different assigned errand locations.

Group II: PACE (physical and cognitive exercise)Active Control1 Intervention

PACE (Physical and Cognitive Exercise) involves a "pedal-while-play" experience in which physical and mental exercise are combined in a simultaneous, but not fully interactive way. In this condition a person will pedal while also separately steering in a tablet-based game, such as when pedaling while automatically progressing along a virtual path to different assigned errand locations.

Do I qualify?Apply below to find out